SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Operating Cash Flow

Cash generated by the company's core business operations during the period.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow of -$13.54M in Q1 FY2026

Q1 FY2026 operating cash flow was -$13.54M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$13.54M+45.1% QoQ
Last fiscal yearDec 2025
-$32.7M— YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
(32.7M) USD
Year-over-year change
—

Operating Cash Flow vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Operating Cash Flow for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$2.34B USD+14.1%+23.1%21.4%
BLCOBausch + Lomb CorporationLTM Jun 2026$458.39M USD+146.4%-6.4%8.6%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$267.54M USD+80.6%+54.6%3513.3%
OCULOcular Therapeutix, Inc.LTM Mar 2026$226.21M USD+55.5%+50.9%434.7%
OCSOculis Holding AGLTM Mar 2026CHF 62.18M CHF+16.7%+35.4%12337.0%
STAASTAAR Surgical CompanyLTM Apr 2026$50.19M USD+329.4%—17.3%
SGPSpyGlass Pharma, Inc. Common StockFY2025$32.7M USD———
SGHTSight Sciences, Inc.LTM Mar 2026$25.12M USD+3.9%-26.9%31.6%
RXSTRxSight, Inc.LTM Mar 2026$17.57M USD+6.7%-35.9%13.8%
GKOSGlaukos CorporationLTM Jun 2026$950K USD-95.4%+11.9%0.2%
Peer median (excluding SGP) —+16.7%+17.5%21.4%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.